Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17
- 12 May 2022
- journal article
- research article
- Published by Springer Nature in Immunologic Research
- Vol. 70 (4) , 501-517
Abstract
Mycobacterium tuberculosis (Mtb) is responsible for high mortality rates in many low- and middle-income countries. This infectious disease remains accountable for around 1.4 million deaths yearly. Finding effective control measures against Mtb has become imperative. Vaccination has been regarded as the safe and lasting control measure to curtail the impact of Mtb. This study used the Mtb protein biomarker PE_PGRS17 to design a multi-epitope vaccine. A previous study predicted a strong antigenic property of PE_PGRS17. Immunogenic properties such as antigenicity, toxicity, and allergenicity were predicted for the PE_PGRS17 biomarker, specific B- and T-cell epitope sequences, and the final multiple epitope vaccine (MEV) construct. Algorithmic tools predicted the T- and B-cell epitopes and those that met the immunogenic properties were selected to construct the MEV candidate for predicted vaccine development. The epitopes were joined via linkers and an adjuvant was attached to the terminals of the entire vaccine construct. Immunogenic properties, and physicochemical and structural predictions gave insight into the MEV construct. The assembled vaccine candidate was docked with a receptor and validated using web-based tools. An immune simulation was performed to imitate the immune response after exposure to a dosed administrated predicted MEV subunit. An in silico cloning and codon optimisation gave insight into optimal expression conditions regarding the MEV candidate. In conclusion, the generated MEV construct may potentially emit both cellular and humoral responses which are vital in the development of a peptide-based vaccine against Mtb; nonetheless, further experimental validation is still required.Keywords
Funding Information
- Department of Science and Technology, Republic of South Africa (DSI–CSIR Inter-bursary support programme)
- National Research Foundation (117775)
This publication has 49 references indexed in Scilit:
- Risk Factors for TuberculosisPulmonary Medicine, 2013
- T-cell epitope vaccine design by immunoinformaticsOpen Biology, 2013
- Tuberculosis and Poverty: Why Are the Poor at Greater Risk in India?PLOS ONE, 2012
- The Role of TLR2 in Infection and ImmunityFrontiers in Immunology, 2012
- The MycoBrowser portal: A comprehensive and manually annotated resource for mycobacterial genomesTuberculosis, 2011
- PE_PGRS Antigens of Mycobacterium tuberculosis Induce Maturation and Activation of Human Dendritic CellsThe Journal of Immunology, 2010
- I-TASSER: a unified platform for automated protein structure and function predictionNature Protocols, 2010
- ElliPro: a new structure-based tool for the prediction of antibody epitopesBMC Bioinformatics, 2008
- ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteinsNucleic Acids Research, 2007
- Are the PE‐PGRS proteins of Mycobacterium tuberculosis variable surface antigens?Molecular Microbiology, 2002